# Beta-cell Response to Incretin Hormones in Cystic Fibrosis

> **NCT01851694** · NA · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 45 (estimated)

## Conditions studied

- Cystic Fibrosis
- Pancreatic Insufficiency

## Interventions

- **DRUG:** GLP-1
- **DRUG:** GIP

## Key facts

- **NCT ID:** NCT01851694
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-05
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851694, "Beta-cell Response to Incretin Hormones in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01851694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*